特色簡介
2016年國民健康署癌症年報，臺灣2016年間約有一萬五千名女性被診斷出罹患乳癌或乳房原位癌，為女性十大癌症之首，更是女性健康威脅。
2015年引進國外行之有年的乳癌體內微管放射治療，成為手術後放射治療的新選擇。
治療方式
在麻醉下將乳房專用微管置入原腫瘤的位置，再將銥192治療核種經此微管送入該區域短暫停留。治療完成後立即移除。從微管置放術到完成治療移除微管，約需住院5-7天。在放射腫瘤專科醫師及乳房外專科醫師合作下，依治療體積將7至15支微管埋放在原腫瘤所在之區域。體內微管放射治療時間為20-30分鐘，早晚各一次，需要4至10次的治療。減少照射體積，治療核種光子能量低，組織穿透距離短，周邊正常器官的劑量較傳統治療降低約50%~80%，故降低急性皮膚反應和後續心臟及肺臟的影響。微管拔除後皮膚上有細小的穿刺傷口，可能有微出血及後續傷口照護問題。
適用病症
根據美國、歐洲放射腫瘤學會、與高榮乳癌團隊準則，大於45歲，腫瘤小於3公分，無淋巴轉移的單一個乳管癌或原位癌，ER荷爾蒙受體陽性，與足夠的安全距離等適應症。建議與專業醫師溝通討論各項風險因素，透過嚴格評估標準選擇適合治療方式。
醫療團隊
- 放射腫瘤部劉文山醫師
- 放射腫瘤部黃俞憲醫師
- 放射腫瘤部簡茹君醫師
- 一般外科陳玉佳醫師
洽詢電話
連結網址
得獎資訊
- 2018年 社團法人國家生技醫療產業策進會 SNQ國家品質標章 早期乳癌放射治療的新境界
- 2017年 衛生福利部 醫病共享決策( SDM)輔助工具競賽銀獎 早期乳癌或乳房原位癌接受部份乳房切除術後，我該選擇哪一種手術後放射治療？
---------------------------------
According to the data of Taiwan Ministry of Health and Welfare, breast cancer is the leading cause of cancer in women. There were more than ten thousand persons per year, and over two thousand women died of it. It means that there were 31 women diagnosed with breast cancer and 6 died of it per day, respectively. Among them, early stage breast cancer (stage 0 and 1) accounted for 48.9%, and more than half patient received radiotherapy. Therefore, planning an innovative radiotherapy program for early breast cancer is an important medical and health care topic.
The traditional technique of whole breast external beam radiotherapy for early-stage breast cancer takes four to six weeks, often causing inconvenience for patients to seek medical treatment and family care. In addition, many studies reported the chronic side effects for this kind of patients with or without family history. To solve these problems, Kaohsiung Veterans General Hospital is the first hospital to introduce interstitial brachytherapy (ISBT) in Taiwan. The ISBT has two major advantages. First, it reduces the health care burden by diminishing treatment time to 3 days. Second, it reduces the nearby organ’s chronic side-effects by massively reducing the radiation dose to heart and lung. Hence, it is a major breakthrough for early stage breast cancer management and the right way to approach the holistic medicine.